Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

<< Previous

Bullboard Posts

Next >>

Post by Duster340on Dec 08, 2021 1:25am

495 Views

Post# 34209188

I See More RSU

are being handed out, also the employee's who's vested rsu into stock have got to be pizzed off, 5333 shares of vibe @70 cents = $3733. i am sure they were expecting a lot more only a few months ago. probly some disgruntled employees there.

Insider Filings

Latest 10 SEDI filings for ATE within the last 6 months

View on INK Research

Amended Filing

As of 11:59pm ET December 7th, 2021

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value
Dec 1/21	Nov 29/21	Wu, Yung Cheng	Direct Ownership	Common Shares	57 - Exercise of rights	5,333
Dec 1/21	Nov 29/21	Wu, Yung Cheng	Direct Ownership	Restricted Share Units	57 - Exercise of rights	-5,333
Dec 1/21	Nov 29/21	Flower, Roderick John	Direct Ownership	Common Shares	57 - Exercise of rights	5,333
Dec 1/21	Nov 29/21	Flower, Roderick John	Direct Ownership	Restricted Share Units	57 - Exercise of rights	-5,333
Dec 1/21	Nov 29/21	Macnee, Walter Minnes	Direct Ownership	Common Shares	57 - Exercise of rights	5,333
Dec 1/21	Nov 29/21	Macnee, Walter Minnes	Direct Ownership	Restricted Share Units	57 - Exercise of rights	-5,333
Nov 19/21	Nov 15/21	Wilson, Alain	Indirect Ownership	Restricted Share Units	56 - Grant of rights	20,000
Nov 19/21	Nov 15/21	Stegic, Ana	Direct Ownership	Restricted Share Units	56 - Grant of rights	10,000
Nov 19/21	Nov 15/21	Curtis, Scott Wilson	Direct Ownership	Restricted Share Units	56 - Grant of rights	30,000
Nov 19/21	Nov 15/21	Vaughan, David James	Direct Ownership	Restricted Share Units	56 - Grant of rights	30,000